During the past decade, Europejskie Centrum Zdrowia Otwock Szpital im. Fryderyka Chopina, Klinika Onkologii conducted 26 clinical trials. In the 10-year time frame, 26 clinical trials started and 17 clinical trials were completed, i.e. on average, 65.4% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 13 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Europejskie Centrum Zdrowia Otwock Szpital im. Fryderyka Chopina, Klinika Onkologii" #1 sponsor was "Hoffmann-La Roche" with 9 trials, followed by "Pfizer" with 4 trials sponsored, "United Therapeutics" with 4 trials sponsored, "AVEO Pharmaceuticals, Inc." with 2 trials sponsored and "Acceleron Pharma Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary of Merck & Co., Inc.)" with 2 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Europejskie Centrum Zdrowia Otwock Szpital im. Fryderyka Chopina, Klinika Onkologii" #1 collaborator was "Astellas Pharma Inc" with 1 trials as a collaborator, "Austrian Breast and Colorectal Cancer Group" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator and "Chugai" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Europejskie Centrum Zdrowia Otwock Szpital im. Fryderyka Chopina, Klinika Onkologii" are "Pulmonary Arterial Hypertension" (7 trials), "Breast Cancer" (5 trials), "Breast Neoplasms" (3 trials), "Hypertension, Pulmonary" (3 trials) and "PAH" (3 trials). Many other conditions were trialed in "Europejskie Centrum Zdrowia Otwock Szpital im. Fryderyka Chopina, Klinika Onkologii" in a lesser frequency.

Most popular intervention types in "Europejskie Centrum Zdrowia Otwock Szpital im. Fryderyka Chopina, Klinika Onkologii" are "Drug" (31 trials), "Other" (4 trials) and "Biological" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Paclitaxel" (5 trials), "Atezolizumab" (4 trials), "Docetaxel" (4 trials) and "Pertuzumab" (4 trials). Other intervention names were less common.

The vast majority of trials in "Europejskie Centrum Zdrowia Otwock Szpital im. Fryderyka Chopina, Klinika Onkologii" are 30 trials for "All" genders, 3 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Europejskie Centrum Zdrowia Otwock Szpital im. Fryderyka Chopina, Klinika Onkologii". undefined are not yet recruiting, 10 are recruiting, 3 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 18 completed trials in Europejskie Centrum Zdrowia Otwock Szpital im. Fryderyka Chopina, Klinika Onkologii, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Europejskie Centrum Zdrowia Otwock Szpital im. Fryderyka Chopina, Klinika Onkologii, 2 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 24 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".

Europejskie Centrum Zdrowia Otwock Szpital im. Fryderyka Chopina, Klinika Onkologii has several departments that took part in Clinical trials: "ECZ Otwock Klinika Kardiologii, Klinika Krążenia Płucnego Chorób Zakrzepowo-Zatorowych i Kardiologii" - 2 trials